MENU
DSGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Design Therapeutics (DSGN) Ownership - Who owns Design Therapeutics?
Profile
Industry
N/A
Address
6005 Hidden Valley Road
Phone
+1 858 293-4900
Employees
124
Web
https://www.designtx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
353.88M
P/E Ratio
N/A
Total Cash
254.07M
Projected Growth
N/A
Total Debt
2.52M
Revenue
N/A
Risk (Beta)
2.08
Dividend Yield
N/A
Total Cash/Share
4.49
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
DSGN
Capitalization
354M
P/E Ratio
N/A
Risk (Beta)
2.08
Dividend Yield
N/A
Total Cash
254M
Total Cash/Share
4.49
Total Debt
2.52M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
252M
P/B Ratio
1.40
Cash Flow
N/A
Earnings
-0.85
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
34.61
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-60.23M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-17.02
Shares Held By Institutions
166M
Shares Outstanding - Current
56.6M
Total Liabilities
9.18M
Total Volume MTD
N/A
Value
-1
Gain YTD
135.849
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
6005 Hidden Valley Road
Phone
+1 858 293-4900
Employees
124
Web
https://www.designtx.com